Laia S. A.
- Country
- Spain
- Department
- Nefrologia
Research Overview
- Phase 1 Evaluation of VIS171 Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity in Autoimmune Conditions: Alopecia Areata, Systemic Lupus Erythematosus, and Immune-Mediated Focal Segmental Glomerulosclerosis
- Phase 2 Study of Empasiprubart in Deceased Donor Renal Allograft Recipients at Risk for Delayed Graft Function
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Efgartigimod Alfa SC in Antibody-Mediated Rejection in Kidney Transplant Recipients
Data & Insights
Has run more than one trial at 43 of 169 partner sites.
Specializations
Transplant Rejection Management
This investigator specializes in addressing antibody-mediated rejection in kidney transplant recipients, focusing on innovative therapeutic approaches for transplant survival and patient outcomes.
- Antibody-mediated rejection treatment
- Immunosuppression optimization
- Transplant rejection prevention
Their work encompasses evaluation of novel therapeutic agents for managing transplant rejection complications.
Graft Function Enhancement
The investigator conducts research in improving outcomes for deceased donor kidney transplants, with particular attention to preventing and managing delayed graft function.
- Delayed graft function prevention
- Allograft function optimization
- Post-transplant care protocols
Their research aims to enhance early graft function and improve transplant outcomes through targeted therapeutic interventions.
Long-term Transplant Care
The investigator explores strategies in renal transplantation management, particularly focusing on HLA sensitization prevention and immunosuppression protocols in cases of late graft failure.
- HLA sensitization management
- Late graft failure treatment
- Immunosuppression protocol optimization
Their research examines long-term outcomes in transplant recipients and immunosuppression management strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.